TRANSACT TECHNOLOGIES INC (TACT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 30M 60M 90M Q3 '21: 36M Q4 '21: 39.4M Q1 '22: 40.8M Q2 '22: 44.1M Q3 '22: 51.3M Q4 '22: 58.1M Q1 '23: 70.7M Q2 '23: 78M Q3 '23: 77.3M Q4 '23: 72.6M Q1 '24: 61M Q2 '24: 52.7M Q3 '24: 46.4M Q4 '24: 43.4M Q1 '25: 45.8M Q2 '25: 47.9M Q3 '25: 50.3M Q4 '25: 51.5M Q1 '26: 52.8M Q2 '26: 53M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q3 '21: 13.3M Q4 '21: 15.2M Q1 '22: 14.6M Q2 '22: 16.6M Q3 '22: 20.5M Q4 '22: 24.4M Q1 '23: 34.1M Q2 '23: 39.5M Q3 '23: 40.2M Q4 '23: 38.4M Q1 '24: 31.8M Q2 '24: 27M Q3 '24: 23.3M Q4 '24: 21.5M Q1 '25: 22.2M Q2 '25: 22.8M Q3 '25: 24.1M Q4 '25: 25M Q1 '26: 25.9M Q2 '26: 26.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-15M -10M -5M 0 5M 10M 15M Q3 '19: 2.5M Q4 '20: -8.2M Q1 '21: -9.5M Q2 '21: -9.5M Q3 '21: -9.6M Q4 '21: -9.5M Q1 '22: -12.5M Q2 '22: -12.8M Q3 '22: -10.8M Q4 '22: -7.7M Q1 '23: 1.7M Q2 '23: 5.9M Q3 '23: 6.7M Q4 '24: -3.6M Q1 '25: -2.3M Q2 '25: -2.2M Q3 '25: -1.3M Q4 '25: -1.4M Q1 '26: -629K Q2 '26: -425K Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -5.3M Q4 '21: -4.2M Q1 '22: -6.3M Q2 '22: -6.6M Q3 '22: -7M Q4 '22: -5.9M Q1 '23: 1.6M Q2 '23: 4.7M Q3 '23: 5.1M Q4 '23: 4.7M Q1 '24: 573K Q2 '24: -511K Q3 '24: -2M Q4 '24: -9.9M Q1 '25: -8.8M Q2 '25: -8.6M Q3 '25: -8.1M Q4 '25: -1.2M Q1 '26: -493K Q2 '26: -400K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 15M 30M 45M Q3 '21: 22.7M Q4 '21: 24.2M Q1 '22: 26.2M Q2 '22: 27.5M Q3 '22: 30.8M Q4 '22: 33.7M Q1 '23: 36.6M Q2 '23: 38.5M Q3 '23: 37.1M Q4 '23: 34.2M Q1 '24: 29.3M Q2 '24: 25.7M Q3 '24: 23.1M Q4 '24: 21.9M Q1 '25: 23.5M Q2 '25: 25.2M Q3 '25: 26.2M Q4 '25: 26.5M Q1 '26: 26.9M Q2 '26: 26.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q3 '21: -3.2M Q4 '21: -2.5M Q1 '22: -6.2M Q2 '22: -13.2M Q3 '22: -12.8M Q4 '22: -12.2M Q1 '23: -6.2M Q2 '23: 6.1M Q3 '23: 6.6M Q4 '23: 5.5M Q1 '24: 4.8M Q2 '24: 963K Q3 '24: 389K Q4 '24: 1.9M Q1 '25: 3.2M Q2 '25: 6.1M Q3 '25: 9.5M Q4 '25: 7.7M Q1 '26: 6.9M Q2 '26: 5.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-18M -12M -6M 0 6M 12M 18M Q3 '21: -4.1M Q4 '21: -3.9M Q1 '22: -8M Q2 '22: -15.1M Q3 '22: -14.3M Q4 '22: -13.5M Q1 '23: -7.3M Q2 '23: 4.8M Q3 '23: 5.5M Q4 '23: 4.6M Q1 '24: 4.1M Q2 '24: 508K Q3 '24: -35K Q4 '24: 1.5M Q1 '25: 3M Q2 '25: 6M Q3 '25: 9.4M Q4 '25: 7.6M Q1 '26: 6.7M Q2 '26: 5.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 3.5M 7M 10.5M Q2 '20: 7.5M Q3 '20: 7.5M Q1 '21: 8.9M Q2 '21: 9M Q3 '21: 9.8M Q4 '21: 9.8M Q1 '22: 9.9M Q2 '22: 9.9M Q3 '22: 9.9M Q1 '23: 10M Q2 '23: 10M Q3 '23: 10.1M Q1 '24: 10M Q2 '24: 10M Q3 '24: 10M Q1 '25: 10.1M Q2 '25: 10.1M Q3 '25: 10.2M Q1 '26: 10.2M Q2 '26: 10.3M Q3 '20 Q3 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 Q3 '21: -0.61 Q4 '21: -0.47 Q1 '22: -0.66 Q2 '22: -0.67 Q3 '22: -0.71 Q4 '22: -0.60 Q1 '23: 0.15 Q2 '23: 0.47 Q3 '23: 0.51 Q4 '23: 0.47 Q1 '24: 0.06 Q2 '24: -0.05 Q3 '24: -0.20 Q4 '24: -0.98 Q1 '25: -0.88 Q2 '25: -0.86 Q3 '25: -0.80 Q4 '25: -0.12 Q1 '26: -0.05 Q2 '26: -0.04 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.